Association of marine omega-3 fatty acid levels with telomeric aging in patients with coronary heart disease.

Farzaneh-Far Ramin, et al.
Jama, 2010

Abstract

Context

Increased dietary intake of marine omega-3 fatty acids is associated with prolonged survival in patients with coronary heart disease. However, the mechanisms underlying this protective effect are poorly understood.

Objective

To investigate the association of omega-3 fatty acid blood levels with temporal changes in telomere length, an emerging marker of biological age.
Design, setting, and participants: Prospective cohort study of 608 ambulatory outpatients in California with stable coronary artery disease recruited from the Heart and Soul Study between September 2000 and December 2002 and followed up to January 2009 (median, 6.0 years; range, 5.0-8.1 years).
Main

Outcome measures

We measured leukocyte telomere length at baseline and again after 5 years of follow-up. Multivariable linear and logistic regression models were used to investigate the association of baseline levels of omega-3 fatty acids (docosahexaenoic acid [DHA] and eicosapentaenoic acid [EPA]) with subsequent change in telomere length.

Results

Individuals in the lowest quartile of DHA+EPA experienced the fastest rate of telomere shortening (0.13 telomere-to-single-copy gene ratio [T/S] units over 5 years; 95% confidence interval [CI], 0.09-0.17), whereas those in the highest quartile experienced the slowest rate of telomere shortening (0.05 T/S units over 5 years; 95% CI, 0.02-0.08; P < .001 for linear trend across quartiles). Levels of DHA+EPA were associated with less telomere shortening before (unadjusted beta coefficient x 10(-3) = 0.06; 95% CI, 0.02-0.10) and after (adjusted beta coefficient x 10(-3) = 0.05; 95% CI, 0.01-0.08) sequential adjustment for established risk factors and potential confounders. Each 1-SD increase in DHA+EPA levels was associated with a 32% reduction in the odds of telomere shortening (adjusted odds ratio, 0.68; 95% CI, 0.47-0.98).

Conclusion

Among this cohort of patients with coronary artery disease, there was an inverse relationship between baseline blood levels of marine omega-3 fatty acids and the rate of telomere shortening over 5 years.

PMID:20085953
PMCID (Free PMC Article):PMC2819264
DOI:10.1001/jama.2009.2008
Category:Cardiovascular Support

The best supplements with Omega-3 Acids in Cardiovascular Support category:

Articles similar to "Association of marine omega-3 fatty acid levels with telomeric aging in patients with coronary heart disease."

  • The significance of Omega-3 Acids for Cardiovascular Support: Marine OMEGA-3 Fatty Acids in the Prevention of Cardiovascular Disease. (Omega-6 (ω6) and omega-3 (ω3) fatty acids are two classes of dietary polyunsaturated fatty acids derived from linoleic acid (18:2ω6) and Alpha-Linolenic Acid (18:3ω3), respectively...)
  • The role of Omega-3 Acids in Cardiovascular Support: Omega-3 Fatty Acids and Cardiovascular Disease. (Cardioceuticals are nutritional supplements that contain all the essential nutrients including vitamins, minerals, omega-3-fatty acids and other antioxidants like a-lipoic acid and coenzyme Q10 in the right proportion that provide all round protection to the heart by reducing the most common risks associated with the cardiovascular disease including high low-density lipoprotein cholesterol and triglyceride levels and factors that contribute to coagulation of blood...)
  • The impact of Omega-3 Acids on Cardiovascular Support: New Insights Into Mechanisms of Action for Omega-3 Fatty Acids in Atherothrombotic Cardiovascular Disease. (Purpose of review: Treatment of hypercholesterolemia with statins results in significant reductions in cardiovascular risk; however, individuals with well-controlled low-density lipoprotein cholesterol (LDL-C) levels, but persistent high triglycerides (TG), remain at increased risk...)

Previous article

Potassium, magnesium, and electrolyte imbalance and complications in disease management.

Next article

Potential Synergies of β-Hydroxybutyrate and Butyrate on the Modulation of Metabolism, Inflammation, Cognition, and General Health.